Mobic 7.5mg / 15mg Tablet
PDF Leaflet Revision Date: 15 April 2011
Clinical Summary
Quick overview from the medicine insert
Indication
Symptomatic treatment of rheumatoid arthritis, osteoarthritis, ankylosing spondylitis, and acute sciatica.
Dosage (summary)
Rheumatoid arthritis: 15 mg/day, may reduce to 7.5 mg. Osteoarthritis: 7.5 mg/day, may increase to 15 mg.
Onset of Action / Duration
Onset: 5-6 hours, Duration: 20 hours
Special Populations
- Elderly
- Hepatic impairment
- Renal impairment
Pregnancy & Breastfeeding
Contra-indicated in pregnancy and breastfeeding; may impair fertility.
Key Drug Interactions
- Increased risk of bleeding with anticoagulants
- Increased lithium levels
- Reduced methotrexate clearance
Contraindications
- Hypersensitivity to meloxicam
- Active gastrointestinal ulceration
- Severe hepatic/renal insufficiency
- Children under 12 years
Common side effects
- Gastrointestinal disorders
- Headache
- Dizziness
- Nausea
Counselling Points
- Take with food
- Monitor for gastrointestinal symptoms
- Avoid in dehydration
Serious warnings
- Risk of gastrointestinal bleeding
- Serious skin reactions
- Caution in cardiovascular disease
Important Disclaimer
The Mobic 7.5mg / 15mg Tablet professional information leaflet below is the property of Boehringer Ingelheim and is provided on Medinsert exactly as issued, with no.. alterations or editorial changes. We make every effort to keep content current by updating documents as soon as new versions become available. Medinsert serves as a trusted access point for healthcare professionals, but does not replace official sources or clinical judgement. For more details, please read our full disclaimer. read more>>
Healthcare Professionals Only
This content is for registered healthcare professionals
Sign in or create a free account to read the full package insert.
Free for HPCSA-registered professionals. Powered by Medinsert.
